Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis

References

• Adams JM, Cory S. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61–66.
   PubMed Web of Science ®Google Scholar
• Aranganathan S, Panneer Selvam J, Nalini N. 2009. Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 27:203–213.
   PubMed Web of Science ®Google Scholar
• Bobek P, Galbavy S. 2001. Influence of inulin on dimethylhydrazine induced carcinogenesis and antioxidant enzymatic system in rat. Biologia (Bratisl) 56:287–291.
   Google Scholar
• Boland CR, Luciani MG, Gasche C, Goel A. 2005. Infection, inflammation, and gastrointestinal cancer. Gut 54:1321–1331.
   PubMed Web of Science ®Google Scholar
• Cai Y, Luo Q, Sun M, Corke H. 2004. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 74:2157–2184.
   PubMed Web of Science ®Google Scholar
• Castellone MD, Teramoto H, Gutkind JS. 2006. Cyclooxygenase-2 and colorectal cancer chemoprevention: The β-catenin connection. Cancer Res 66:11085–11088.
   PubMed Web of Science ®Google Scholar
• Choi EJ, Kim GD, Chee KM, Kim GH. 2006. Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition 22:947–951.
   Google Scholar
• Choi EM, Kim YH. 2008. Hesperetin attenuates the highly reducing sugar-triggered inhibition of osteoblast differentiation. Cell Biol Toxicol 24:225–231.
   PubMed Web of Science ®Google Scholar
• Choi GS, Lee S, Jeong TS, Lee MK, Lee JS, Jung UJ, Kim HJ, Park YB, Bok SH, Choi MS. 2004. Evaluation of hesperetin 7-O-lauryl ether as lipid-lowering agent in high-cholesterol-fed rats. Bioorg Med Chem 12:3599–3605.
   PubMed Web of Science ®Google Scholar
• Crew TE, Elder DJ, Paraskeva C. 2000. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: Regulation of COX-2 by butyrate. Carcinogenesis 21:69–77.
   Google Scholar
• Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R, Kroemer G.. 1997. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents Cancer Res 57:62–67.
   PubMed Web of Science ®Google Scholar
• DuBois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259–1262.
   PubMed Web of Science ®Google Scholar
• Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188.
   PubMed Web of Science ®Google Scholar
• Goel A, Arnold CN, Boland CR. 2001. Multistep progression of colorectal cancer in the setting of microsatellite instability: New details and novel insights. Gastroenterology 121:1497–1502.
   Google Scholar
• Halin C, Niesner U, Villani ME, Zardi L, Neri D. 2002. Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins. Int J Cancer 102:109–116.
   PubMed Web of Science ®Google Scholar
• Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. 1990. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294.
   PubMed Web of Science ®Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13:572–584.
   PubMed Web of Science ®Google Scholar
• Huls G, Koornstra JJ, Kleibeuker JH. 2003. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362:230–232.
   PubMed Web of Science ®Google Scholar
• Jackson PE, O’Connor PJ, Cooper DP, Margison GP, Povey AC. 2003. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24:527–533.
   PubMed Web of Science ®Google Scholar
• Jänne PA, Mayer RJ. 2000. Chemoprevention of colorectal cancer. N Engl J Med 342:1960–1968.
   PubMed Web of Science ®Google Scholar
• Johnson GC, Miller MA, Ramos-Vara JA. 1995. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J Vet Diagn Invest 7:127–136.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jung KJ, Choi JS, Chung HY. 2004. Hesperetin: A potent antioxidant against peroxynitrite. Free Radic Res 38:761–769.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jung KJ, Choi JS, Chung HY. 2006. Modulation of the age-related nuclear factor-κB (NF-κB) pathway by hesperetin. Aging Cell 5:401–411.
   PubMed Web of Science ®Google Scholar
• Kim YI, Mason JB. 1996. Nutrition chemoprevention of gastrointestinal cancers: A critical review. Nutr Rev 54:259–279.
   PubMed Web of Science ®Google Scholar
• Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. 2002. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560–568.
   PubMed Web of Science ®Google Scholar
• Kohno H, Yamaguch K, Taima M, Tanaka T. 2002. Prevention of colonic aberrant crypt foci by dietary feeding of chalcone and 2-hydroxy chalocone in male F344 rats. J Toxicol Pathol 15:137–143.
   Google Scholar
• Laemmeli UK.. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227:680–685.
   PubMed Web of Science ®Google Scholar
• Lee NK, Choi SH, Park SH, Park EK, Kim DH. 2004. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 71:174–180.
   PubMed Web of Science ®Google Scholar
• Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. 2001. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2:612–619.
   PubMed Web of Science ®Google Scholar
• Li M, Ye C, Feng C, Riedel F, Liu X, Zeng Q, Grandis JR. 2002. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Clin Cancer Res 8:3570–3578.
   PubMed Web of Science ®Google Scholar
• Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE. 2000. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clin Cancer Res 6:4287–4291.
   Google Scholar
• Mattern J, Koomägi R, Volm M. 1997. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 17:2249–2252.
   PubMed Web of Science ®Google Scholar
• Murray PG, Boldy DA, Crocker J, Ayres JG. 1989. Sequential demonstration of antigens and AgNORs in frozen and paraffin sections. J Pathol 159:169–172.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim MJ, Ha E, Chung JH. 2008. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 15:147–151.
   PubMed Web of Science ®Google Scholar
• Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jäger R, Weiher H, Furth PA. 1999. Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59:2541–2545.
   PubMedGoogle Scholar
• Singh RP, Banerjee S, Kumar PV, Raveesha KA, Rao AR. 2006. Tinospora cordifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 13:74–84.
   PubMed Web of Science ®Google Scholar
• Shibata MA, Ito Y, Morimoto J, Otsuki Y.. 2004. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinomamodel: a p53-independent mitochondrial-mediated apoptotic mechanism Carcinogenesis 25:1887–1898.
   PubMed Web of Science ®Google Scholar
• Shrikhande SV, Saoji RR, Barreto SG, Kakade AC, Waterford SD, Ahire SB, Goliwale FM, Shukla PJ. 2007. Outcomes of resection for rectal cancer in India: The impact of the double stapling technique. World J Surg Oncol 5:35.
   Google Scholar
• Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. 2002. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 62:6323–6328.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Wakabayashi K. 2004. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95:475–480.
   PubMed Web of Science ®Google Scholar
• Takashashi T, Masaki B, Hoyoku N, Toru O. 2006. Cyclooxygenase-2 play a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells. Cancer Lett 231:319–325.
   Google Scholar
• Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cycloxygenase regulates angiogenesis induced by colon cancer cells. Cell.
   Google Scholar
• Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. 1990. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664–1672.
   PubMed Web of Science ®Google Scholar
• Yu HP, Xu SQ, Liu L, Shi LY, Cai XK, Lu WH, Lu B, Su YH, Li YY. 2003. Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus. Cancer Lett 198:193–201.
   PubMed Web of Science ®Google Scholar
• Zang XQ. 1996. Progress of study on suppresser, EGFR and PCNA in colorectal cancer. Xin Xiaohuabingxue Zazhi; 4:327–328.
   Google Scholar